Cover |
12 Months Ended |
|---|---|
|
Oct. 31, 2025
shares
| |
| Document Information [Line Items] | |
| Document Type | 20-F/A |
| Document Registration Statement | false |
| Document Annual Report | true |
| Document Transition Report | false |
| Document Financial Statement Error Correction [Flag] | false |
| Document Shell Company Report | false |
| Entity Interactive Data Current | Yes |
| Document Accounting Standard | U.S. GAAP |
| ICFR Auditor Attestation Flag | false |
| Amendment Flag | true |
| Amendment Description | This Amendment No. 2 on Form 20-F/A (the “Form 20-F/A”) amends the annual report on Form 20-F of Park Ha Biological Technology Co., Ltd. (the “Company,” “we” or “our”) for the fiscal year ended October 31, 2025, originally filed with the U.S. Securities and Exchange Commission (“SEC”) on March 2, 2026 (the “Form 20-F”), and Amendment No.1 to the Original Form 20-F (“Amendment 1”) filed with the SEC on April 29, 2026. This Form 20-F/A is being filed in response to the comment letter dated May 8, 2026 (the “SEC Comment Letter”) from the staff of the SEC and relates to matters discussed in the SEC Comment Letter. Item 4. Information on the Company to provide additional disclosure on the VIE agreements. Item 5. Operating and Financial Review and Prospects of Part I in the Form 20-F is amended by this Form 20-F/A to include additional disclosures regarding the franchise fees, the share-based compensation expense, the credit losses and the compensation. No other changes have been made to the Original Form 20-F or Amendment 1.This Amendment No. 2 on Form 20-F/A speaks as of the filing date of the Form 20-F on March 2, 2026. Other than as set forth herein, the Form 20-F/A does not, and does not purport to, amend, update or restate any other information or disclosure included in the Form 20-F or reflect any events that have occurred since March 2, 2026. |
| Document Period End Date | Oct. 31, 2025 |
| Document Fiscal Year Focus | 2025 |
| Document Fiscal Period Focus | FY |
| Entity Information [Line Items] | |
| Entity Registrant Name | Park Ha Biological Technology Co., Ltd. |
| Entity Central Index Key | 0001986247 |
| Entity File Number | 001-42453 |
| Entity Incorporation, State or Country Code | E9 |
| Current Fiscal Year End Date | --10-31 |
| Entity Well-known Seasoned Issuer | No |
| Entity Voluntary Filers | No |
| Entity Current Reporting Status | Yes |
| Entity Shell Company | false |
| Entity Filer Category | Non-accelerated Filer |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
| Entity Contact Personnel [Line Items] | |
| Entity Address, Address Line One | 901, Building C |
| Entity Address, Address Line Two | Phase 2, Wuxi International Life Science Innovation Campus |
| Entity Address, Address Line Three | 196 Jinghui East Road |
| Entity Address, City or Town | Wuxi |
| Entity Address, Country | CN |
| Entity Address, Postal Zip Code | 214000 |
| Entity Listings [Line Items] | |
| Title of 12(b) Security | Ordinary Shares, par value $0.001 per share |
| Trading Symbol | BYAH |
| Security Exchange Name | NASDAQ |
| Class A Ordinary Share | |
| Entity Listings [Line Items] | |
| Entity Common Stock, Shares Outstanding | 296,488 |
| Class B Ordinary Shares | |
| Entity Listings [Line Items] | |
| Entity Common Stock, Shares Outstanding | 381,000 |
| Business Contact [Member] | |
| Entity Contact Personnel [Line Items] | |
| Contact Personnel Name | Xiaoqiu Zhang |
| Contact Personnel Email Address | ir@parkha.cn |
| Entity Address, Address Line One | 901, Building C |
| Entity Address, Address Line Two | Phase 2, Wuxi International Life Science Innovation Campus |
| Entity Address, Address Line Three | 196 Jinghui East Road |
| Entity Address, City or Town | Wuxi |
| Entity Address, Country | CN |
| Entity Address, Postal Zip Code | 214000 |
| Entity Phone Fax Numbers [Line Items] | |
| City Area Code | +86 |
| Local Phone Number | 400 012 7562 |